Antibody nanoparticles override immunological tolerance of tumors
| Date | 16th, Jul 2019 |
|---|---|
| Source | Nanowerk - Nanotechnology Websites |
DESCRIPTION
Scientists have developed a tumor enzymatic microenvironment-activatable antibody nanoparticle for robust cancer immunotherapy.